MORPHOSYS AG (MOR.DE) Fundamental Analysis & Valuation

FRA:MOR • DE0006632003

Current stock price

67.25 EUR
-0.45 (-0.66%)
Last:

This MOR.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MOR.DE Profitability Analysis

1.1 Basic Checks

  • MOR had negative earnings in the past year.
  • MOR had a negative operating cash flow in the past year.
  • MOR had negative earnings in 4 of the past 5 years.
  • MOR had negative operating cash flow in 4 of the past 5 years.
MOR.DE Yearly Net Income VS EBIT VS OCF VS FCFMOR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M

1.2 Ratios

  • With a Return On Assets value of -25.13%, MOR perfoms like the industry average, outperforming 57.33% of the companies in the same industry.
Industry RankSector Rank
ROA -25.13%
ROE N/A
ROIC N/A
ROA(3y)-11.93%
ROA(5y)-10.13%
ROE(3y)-230.96%
ROE(5y)-140.65%
ROIC(3y)N/A
ROIC(5y)N/A
MOR.DE Yearly ROA, ROE, ROICMOR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

  • Looking at the Gross Margin, with a value of 83.89%, MOR belongs to the top of the industry, outperforming 85.33% of the companies in the same industry.
  • MOR's Gross Margin has declined in the last couple of years.
  • MOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.84%
GM growth 5Y-4.24%
MOR.DE Yearly Profit, Operating, Gross MarginsMOR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MOR.DE Health Analysis

2.1 Basic Checks

  • MOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MOR has been increased compared to 1 year ago.
  • Compared to 1 year ago, MOR has an improved debt to assets ratio.
MOR.DE Yearly Shares OutstandingMOR.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
MOR.DE Yearly Total Debt VS Total AssetsMOR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.33, we must say that MOR is in the distress zone and has some risk of bankruptcy.
  • MOR has a Altman-Z score (1.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACC6.96%
MOR.DE Yearly LT Debt VS Equity VS FCFMOR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M 600M

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that MOR should not have too much problems paying its short term obligations.
  • The Current ratio of MOR (1.38) is worse than 66.67% of its industry peers.
  • A Quick Ratio of 1.38 indicates that MOR should not have too much problems paying its short term obligations.
  • MOR's Quick ratio of 1.38 is in line compared to the rest of the industry. MOR outperforms 42.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.38
MOR.DE Yearly Current Assets VS Current LiabilitesMOR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MOR.DE Growth Analysis

3.1 Past

  • MOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.42%.
  • The Revenue for MOR has decreased by -31.97% in the past year. This is quite bad
  • Measured over the past years, MOR shows a very strong growth in Revenue. The Revenue has been growing by 25.53% on average per year.
EPS 1Y (TTM)-160.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-518.18%
Revenue 1Y (TTM)-31.97%
Revenue growth 3Y-10.08%
Revenue growth 5Y25.53%
Sales Q2Q%-55.81%

3.2 Future

  • MOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.67% yearly.
  • The Revenue is expected to grow by 33.46% on average over the next years. This is a very strong growth
EPS Next Y20.86%
EPS Next 2Y18.1%
EPS Next 3Y21.29%
EPS Next 5Y23.67%
Revenue Next Year-3.33%
Revenue Next 2Y12.61%
Revenue Next 3Y22.79%
Revenue Next 5Y33.46%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MOR.DE Yearly Revenue VS EstimatesMOR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
MOR.DE Yearly EPS VS EstimatesMOR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

1

4. MOR.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • MOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MOR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOR.DE Price Earnings VS Forward Price EarningsMOR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MOR.DE Per share dataMOR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MOR's earnings are expected to grow with 21.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.1%
EPS Next 3Y21.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MOR.DE Dividend Analysis

5.1 Amount

  • MOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MOR.DE Fundamentals: All Metrics, Ratios and Statistics

MORPHOSYS AG

FRA:MOR (8/2/2024, 7:00:00 PM)

67.25

-0.45 (-0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-29
Earnings (Next)08-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.13B
Revenue(TTM)203.50M
Net Income(TTM)-460.27M
Analysts70
Price Target55.59 (-17.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-57555.5%
Min EPS beat(2)-115317%
Max EPS beat(2)206.19%
EPS beat(4)2
Avg EPS beat(4)-28776.9%
Min EPS beat(4)-115317%
Max EPS beat(4)206.19%
EPS beat(8)4
Avg EPS beat(8)-14366.3%
EPS beat(12)6
Avg EPS beat(12)-9590.79%
EPS beat(16)8
Avg EPS beat(16)-7188.44%
Revenue beat(2)0
Avg Revenue beat(2)-26.57%
Min Revenue beat(2)-49.34%
Max Revenue beat(2)-3.8%
Revenue beat(4)0
Avg Revenue beat(4)-15.03%
Min Revenue beat(4)-49.34%
Max Revenue beat(4)-2.92%
Revenue beat(8)4
Avg Revenue beat(8)2.63%
Revenue beat(12)7
Avg Revenue beat(12)3.04%
Revenue beat(16)11
Avg Revenue beat(16)8.21%
PT rev (1m)-2.68%
PT rev (3m)-2.68%
EPS NQ rev (1m)3.95%
EPS NQ rev (3m)9.81%
EPS NY rev (1m)8.07%
EPS NY rev (3m)-15.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.71%
Revenue NY rev (1m)-5.17%
Revenue NY rev (3m)-6.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 49.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-12.37
EYN/A
EPS(NY)-3.35
Fwd EYN/A
FCF(TTM)-2
FCFYN/A
OCF(TTM)-1.98
OCFYN/A
SpS1.35
BVpS-1.74
TBVpS-9.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.89%
FCFM N/A
ROA(3y)-11.93%
ROA(5y)-10.13%
ROE(3y)-230.96%
ROE(5y)-140.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.84%
GM growth 5Y-4.24%
F-Score2
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.32%
Cap/Sales 1.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.38
Altman-Z 1.33
F-Score2
WACC6.96%
ROIC/WACCN/A
Cap/Depr(3y)143.67%
Cap/Depr(5y)216.4%
Cap/Sales(3y)7.08%
Cap/Sales(5y)8.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-518.18%
EPS Next Y20.86%
EPS Next 2Y18.1%
EPS Next 3Y21.29%
EPS Next 5Y23.67%
Revenue 1Y (TTM)-31.97%
Revenue growth 3Y-10.08%
Revenue growth 5Y25.53%
Sales Q2Q%-55.81%
Revenue Next Year-3.33%
Revenue Next 2Y12.61%
Revenue Next 3Y22.79%
Revenue Next 5Y33.46%
EBIT growth 1Y-97.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.77%
EBIT Next 3Y26.15%
EBIT Next 5Y18.59%
FCF growth 1Y50.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.85%
OCF growth 3YN/A
OCF growth 5YN/A

MORPHOSYS AG / MOR.DE Fundamental Analysis FAQ

What is the fundamental rating for MOR stock?

ChartMill assigns a fundamental rating of 2 / 10 to MOR.DE.


What is the valuation status of MORPHOSYS AG (MOR.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to MORPHOSYS AG (MOR.DE). This can be considered as Overvalued.


How profitable is MORPHOSYS AG (MOR.DE) stock?

MORPHOSYS AG (MOR.DE) has a profitability rating of 1 / 10.